Literature DB >> 10778420

Cancer genetics in primary care. When is genetic screening an option and when is it the standard of care?

L J Elsas1, A Trepanier.   

Abstract

In some families, predisposition to cancer is caused by a germline mutation in a single gene, which produces an autosomal dominant pattern of cancer transmission. Several hereditary cancer syndromes have been identified and for many of them, genetic testing is clinically available. Determining which patients are at risk for hereditary cancer begins by taking a complete family history. In particular, a three-generation family history and pedigree can provide valuable information for both patients and primary care physicians. When the history supports the possibility of hereditary cancer, a qualified genetic professional can assist with specific advice about testing and treatment options for the entire family. If pedigree analysis substantiates a heritable form of cancer, patients should be thoroughly informed about potential benefits, limitations, and risks of genetic screening and offered testing as appropriate. The ultimate goal is to reduce cancer morbidity and mortality through interventions that decrease cancer risk or increase early detection.

Entities:  

Mesh:

Year:  2000        PMID: 10778420     DOI: 10.3810/pgm.2000.04.1000

Source DB:  PubMed          Journal:  Postgrad Med        ISSN: 0032-5481            Impact factor:   3.840


  3 in total

1.  Cancer risk assessment by rural and Appalachian family medicine physicians.

Authors:  Kimberly M Kelly; Margaret M Love; Kevin A Pearce; Kyle Porter; Mary A Barron; Michael Andrykowski
Journal:  J Rural Health       Date:  2009       Impact factor: 4.333

2.  Use of an educational computer program before genetic counseling for breast cancer susceptibility: effects on duration and content of counseling sessions.

Authors:  Michael J Green; Susan K Peterson; Maria Wagner Baker; Lois C Friedman; Gregory R Harper; Wendy S Rubinstein; June A Peters; David T Mauger
Journal:  Genet Med       Date:  2005-04       Impact factor: 8.822

3.  Promotion of cancer family history awareness: Jameslink Cancer Risk Assessment Tool at community health fairs.

Authors:  Kimberly M Kelly; Kyle Porter; Amber Remy; Judith A Westman
Journal:  J Genet Couns       Date:  2008-05-17       Impact factor: 2.537

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.